These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 23413276)
21. Early diagnosis of acute kidney injury: the promise of novel biomarkers. Soni SS; Ronco C; Katz N; Cruz DN Blood Purif; 2009; 28(3):165-74. PubMed ID: 19590184 [TBL] [Abstract][Full Text] [Related]
22. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study. Liu KD; Vijayan A; Rosner MH; Shi J; Chawla LS; Kellum JA Nephrol Dial Transplant; 2016 Oct; 31(10):1641-6. PubMed ID: 27342580 [TBL] [Abstract][Full Text] [Related]
23. The Update of NGAL in Acute Kidney Injury. Shang W; Wang Z Curr Protein Pept Sci; 2017; 18(12):1211-1217. PubMed ID: 27634444 [TBL] [Abstract][Full Text] [Related]
24. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury. Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285 [TBL] [Abstract][Full Text] [Related]
32. Molecular phenotyping of clinical AKI with novel urinary biomarkers. Huen SC; Parikh CR Am J Physiol Renal Physiol; 2015 Sep; 309(5):F406-13. PubMed ID: 26084933 [TBL] [Abstract][Full Text] [Related]
33. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker for the early diagnosis of acute kidney injury (AKI). Antonucci E; Lippi G; Ticinesi A; Pigna F; Guida L; Morelli I; Nouvenne A; Borghi L; Meschi T Acta Biomed; 2014 Dec; 85(3):289-94. PubMed ID: 25567470 [TBL] [Abstract][Full Text] [Related]
34. How to use biomarkers efficiently in acute kidney injury. Lameire NH; Vanholder RC; Van Biesen WA Kidney Int; 2011 May; 79(10):1047-50. PubMed ID: 21527944 [TBL] [Abstract][Full Text] [Related]
35. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment. Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A; Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834 [TBL] [Abstract][Full Text] [Related]
36. Acute kidney injury in severe sepsis: pathophysiology, diagnosis, and treatment recommendations. Keir I; Kellum JA J Vet Emerg Crit Care (San Antonio); 2015; 25(2):200-9. PubMed ID: 25845505 [TBL] [Abstract][Full Text] [Related]
37. Biomarkers for acute kidney injury in critically ill patients. Gonzalez F; Vincent F Minerva Anestesiol; 2012 Dec; 78(12):1394-403. PubMed ID: 23032924 [TBL] [Abstract][Full Text] [Related]
38. A Prospective Study of the Timing and Accuracy of Neutrophil Gelatinase-Associated Lipocalin Levels in Predicting Acute Kidney Injury in High-Risk Cardiac Surgery Patients. Fanning N; Galvin S; Parke R; Gilroy J; Bellomo R; McGuinness S J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):76-81. PubMed ID: 26603784 [TBL] [Abstract][Full Text] [Related]
39. Moderator's view: Patient-centered approaches for optimizing AKI management: the role of kidney biomarkers. Mehta RL Nephrol Dial Transplant; 2017 Mar; 32(3):419-422. PubMed ID: 28375506 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of urinary midkine as a biomarker in patients with acute kidney injury. Hayashi H; Sato W; Kosugi T; Nishimura K; Sugiyama D; Asano N; Ikematsu S; Komori K; Nishiwaki K; Kadomatsu K; Matsuo S; Maruyama S; Yuzawa Y Clin Exp Nephrol; 2017 Aug; 21(4):597-607. PubMed ID: 27530994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]